Pharmacological treatment of ischemic stroke

Pharmacology and Therapeutics

Volumn 108, Issue 3, 2005, Pages 334-352

  Bentley, Paul ^a   Sharma, Pankaj ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebrovascular; Ischemic; Pharmacology; Stroke; Thrombolysis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CLOPIDOGREL; DANAPAROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GLYCERYL TRINITRATE; HEPARIN; HIRUDIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; NICARDIPINE; NITRATE; NITROPRUSSIDE SODIUM; PROPRANOLOL; RAMIPRIL; STATIN; THROMBIN INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; URAPIDIL; WARFARIN; XIMELAGATRAN;

ANTICOAGULATION; AUTOREGULATION; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; EXCITOTOXICITY; HEART ATRIUM FIBRILLATION; HUMAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; OCCUPATIONAL THERAPY; PHYSIOTHERAPIST; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; ULTRASOUND; VASCULAR PATENCY;

ANIMALS; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEUROPROTECTIVE AGENTS; PLATELET AGGREGATION INHIBITORS; THROMBOLYTIC THERAPY;

EID: 28044456553     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.05.006     Document Type: Review

References (153)

1. AbESTT Emergency administration of abciximab for treatment of patients with acute ischemic stroke. Results of a randomized phase 2 trial Stroke 36 4 2005 880 890
2. H.P. Adams Jr., R.F. Woolson, C. Helgason, P.N. Karanjia, and D.L. Gordon Document types: feature low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators JAMA 279 16 1998 1265 1272
3. H.P. Adams, R.J. Adams, T. Brott, G.J. del Zoppo, A. Furlan, and L.B. Goldstein Guidelines for the early management of patients with ischemic stroke Stroke 34 2003 1056 1083
4. A.V. Alexandrov, C.A. Molina, J.C. Grotta, Z. Garami, S.R. Ford, and J. Alvarez-Sabin Ultrasound-enhanced thrombolysis for acute ischemic stroke N Engl J Med 351 21 2004 2170 2178
5. A. Algra, and J. van Gijn Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia J Neurol Neurosurg Psychiatry 60 1996 197 199
6. S. Amin-Hanjani, N.E. Stagliano, M. Yamada, P.L. Huang, J.K. Liao, and M.A. Moskowitz Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice Stroke 32 2001 980 986
7. Antiplatelet Trialists' Collaboration Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
8. S. Aslanyan, F. Fazekas, C.J. Weir, S. Horner, K.R. Lees GAIN International Steering Committee and Investigators Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial Stroke 34 10 2003 2420 2425
9. J. Astrup, B. Siesjö, and L. Symon Thresholds in cerebral ischemia-the ischemic penumbra Stroke 12 1981 723 725
10. BASC (Blood pressure in Acute Stroke Collaboration) Interventions for deliberately altering blood pressure in acute stroke Cochrane Database Syst Rev 3 2001 (CD000039)
11. P.M. Bath, E. Lindenstrom, and G. Boysen Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin controlled trial Lancet 358 2001 702 710
12. C.L. Bennett Thrombotic thrombocytopenic purpura associated with clopidogrel N Engl J Med 342 2000 1773 1777
13. E. Berge, M. Abdelnoor, and P.H. Nakstad Low molecular weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomized study. HAEST Study Group Heparin in Acute Embolic Stroke Trial Lancet 355 2000 1205 1210
14. M.L. Berthier, J. Pujol, A. Gironell, J. Kulisevsky, J. Deus, and J. Hinojosa Beneficial effect of donepezil on sensorimotor function after stroke Am J Phys Med Rehabil 82 9 2003, Sep. 725 729
15. T. Brandt, R. von Kummer, M. Muller Kuppers, and W. Hacke Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome Stroke 27 1996 875 881
16. J.K. Callaway, M. Castillo-Melendez, S.F. Giardina, E.K. Krstew, P.M. Beart, and B. Jarrott Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence Neuropharmacology 47 1 2004, Jul. 146 155
17. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
18. J.P. Casas, L.E. Bautista, L. Smeeth, P. Sharma, and A.D. Hingorani Homocysteine and stroke: evidence on a causal link from Mendelian randomization Lancet 365 2005 224 232
19. CAST Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group Lancet 349 9066 1997 1641 1649
20. CESG: Cerebral Embolism Study Group Immediate anticoagulation of embolic stroke: a randomized trial Stroke 14 1983 668 676
21. A. Chamorro, N. Vila, C. Ascaso, and R. Blanc Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment Arch Neurol 56 9 1999 1098 1102
22. F.K.L. Chan, J.Y.L. Ching, and L.C.T. Hung Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding N Engl J Med 352 2004 238 244
23. Z.M. Chen, P.A.G. Sandercock on behalf of the CAST and IST Collaborative Groups Indications for early aspirin use in acute ischaemic stroke: a combined analysis of over 40,000 randomised patients Stroke 30 243 1999 (abstr)
24. J. Chen, Z.G. Zhang, Y. Li, Y. Wang, L. Wang, and H. Jiang Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke Ann Neurol 53 2003 743 751
25. M.I. Chimowitz, J. Kokkinos, J. Strong, M.B. Brown, S.R. Levine, and S. Silliman The warfarin-aspirin symptomatic intracranial disease study Neurology 45 1995 1488 1493
26. M.I. Chimowitz, M.J. Lynn, H. Howlett-Smith, B.J. Stern, V.S. Hertzberg, and M.R. Frankel For the warfarin-aspirin symptomatic intracranial disease trial investigators N Engl J Med 352 2005 1305 1316
27. I. Christou, and A. Alexandrov Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke Stroke 31 2000 1812 1816
28. W.M. Clark, S. Wissman, and G.W. Albers Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke JAMA 282 1999 2019 2026
29. W.M. Clark, G.W. Albers, and K.P. Madden The rtPA (alteplase) 0- to 6-hour acute stroke trial: Part A (A0276g). Results of a double blind, placebo-controlled, multicenter study. Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators Stroke 31 2000 811 816
30. B. Dahlof, R.B. Devereux, S.E. Kjeldsen LIFE Study Group Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol Lancet 359 9311 2002 995 1003
31. S.F. de Bruijn, and J. Stam Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis Stroke 30 1999 484 488
32. G.J. del Zoppo, K. Poeck, and M.S. Pessin Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 1992 78 86
33. G.J. del Zoppo, R.T. Higashida, and A.J. Furlan PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke Stroke 29 1998 4 11
34. D.B. DeFranco, L. Ho, E. Falke, and C.W. Callaway Small molecule activators of the heat shock response and neuroprotection from stroke Curr Atheroscler Rep 6 4 2004 295 300
35. C. Demougeot, S. Bobillier-Chaumont, C. Mossiat, C. Marie, and A. Berthelot Effect of diets with different magnesium content in ischemic stroke rats Neurosci Lett 362 1 2004 17 20
36. M.S. Dennis, J.P. Burn, P.A. Sandercock, J.M. Bamford, D.T. Wade, and C.P. Warlow Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project Stroke 24 6 1993, June 796 800
37. L. Derex, T.A. Tomsick, and T.G. Brott Outcome of stroke patients without angiographic arterial occlusion AJNR 21 2001 685 690
38. S. Derry, and Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183 1187
39. H.C. Diener, L. Cunha, C. Forbes, J. Sivenius, P. Smets, and A. Lowenthal European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13
40. H.C. Diener, E.B. Ringelstein, and R. von Kummer Treatment of acute ischemic stroke with the low-molecular weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators Stroke 32 2001 22 29
41. H.C. Diener on behalf of the MATCH investigators Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial Lancet 364 2004 331 337
42. G.A. Donnan, S.M. Davis, and B.R. Chambers Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group JAMA 276 1996 961 966
43. S. Dore, T. Otsuka, T. Mito, N. Sugo, T. Hand, and L. Wu Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction Ann Neurol 54 2003 155 162
44. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1993 1255 1262
45. P.J. Eames, M.J. Blake, S.L. Dawson, R.B. Panerai, and J.F. Potter Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke J Neurol Neurosurg Psychiatry 72 2002 467 472
46. Eastern Stroke and Coronary Heart Disease Collaborative Research Group Blood pressure, cholesterol, and stroke in eastern Asia Lancet 352 1998 1801 1807
47. H. Ehrenreich, M. Hasselblatt, C. Dembowski, L. Cepek, and P. Lewczuk Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 8 2002, Aug. 495 505
48. K.M. Einhaupl, A. Villringer, and W. Meister Heparin treatment in sinus venous thrombosis Lancet 338 1991 597 600
49. M. Endres, U. Laufs, and Z. Huang Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc Natl Acad Sci U S A 95 1998 8880 8885
50. A. Evans, I. Perez, G. Yu, and L. Kalra Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation? Stroke 32 2001 2828 2832
51. E. Ferrari, R. Vidal, T. Chevallier, and M. Baudouy Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants J Am Coll Cardiol 33 1999 1317 1322
52. J.B. Fiebach, P.D. Schellinger, and A. Gass Stroke MRI is accurate in hyperacute intracerebral hemorrhage. A multicentre study on the validity of stroke imaging Stroke 35 2 2004 502 506
53. C. Fieschi, C. Argentino, G.L. Lenzi, M.L. Sacchetti, D. Toni, and L. Bozzao Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours J Neurol Sci 91 1989 311 322
54. M.M. Fiore, and V.V. Kakkar Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide Biochem Biophys Res Commun 311 1 2003 71 76
55. G.A. Fitzgerald Coxibs and cardiovascular disease N Engl J Med 351 2004 1709 1711
56. T. Fox, G.F. Hamann, and M. Strittmatter Local intraarterial fibrinolysis in vertebrobasilar thrombosis-prognostic criteria Abstr Cerebrovasc Dis 6 1996 186
57. A. Furlan, R. Higashida, and L. Wechsler Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomised controlled trial. Prolyse in acute cerebral thrombolembolism JAMA 282 1999 2003 2011
58. S. Greisenegger, M. Mullner, S. Tentschert, W. Lang, and W. Lalouschek Effect of pre-treatment with statins on the severity of acute ischemic cerebrovascular events J Neurol Sci 221 2004 5 10
59. J.H. Griffin, J.A. Fernandez, D. Liu, T. Cheng, H. Guo, and B.V. Zlokovic Activated protein C and ischemic stroke Crit Care Med 32 5 Suppl. 2004 S247 S253
60. M. Grond, J. Rudolf, and S. Schmulling Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke Arch Neurol 55 1998 466 469
61. G. Gubitz, C. Counsell, P. Sandercock, and D. Signorini Anticoagulants for acute ischaemic stroke (Cochrane Review) The cochrane library, Issue 1 2004 Wiley Chichester, UK
62. W. Hacke, H. Zeumer, and A. Ferbert Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease Stroke 19 1988 1216 1222
63. W. Hacke, M. Kaste, and C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke (ECASS I) JAMA 274 1995 1017 1025
64. W. Hacke, M. Kaste, and C. Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet 352 1998 1245 1251
65. W. Hacke, T. Brott, and L. Caplan Thrombolysis in acute ischemic stroke: controlled trials and clinical experience Neurology 53 1999 S3 S14
66. W. Hacke, G. Donnan, and C. Fieschi Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 9411 2004 768 774
67. G.J. Hankey, and C.P. Warlow Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations Lancet 354 1999 1457 1463
68. G.J. Hankey, C.L.M. Sudlow, and D.W. Dunbabin Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin in the secondary prevention of stroke and other important vascular events among high risk patients (protocol for a Cochrane Review) The cochrane library 1999 Update Software Oxford Updated quarterly
69. M.R. Harrigan, E.I. Levy, B.R. Bendok, and L.N. Hopkins Bivalirudin for endovascular intervention in acute ischemic stroke: case report Neurosurgery 54 1 2004, Jan. 218 222
70. Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767
71. M. Hommel FISS bis Investigators Group: fraxiparine in ischaemic stroke study Cerebrovasc Dis 8 1998 19 (abstract)
72. M. Hommel, J.P. Boissel, and C. Cornu Termination of trial of streptokinase in severe acute ischaemic stroke Lancet 345 1995 57
73. HOPE: The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
74. International Stroke Trial Collaborative Group The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19,435 patients with acute ischemic stroke Lancet 349 1997 1569 1581
75. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial): randomized controlled trial Lancet 363 2004 439 445
76. ISIS-2 Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 2 (8607) 1988, Aug. 13 349 360
77. O. Jansen, P.D. Schellinger, and J.B. Fiebach Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI Lancet 353 1999 2036 2037
78. E.S. Johnson, S.F. Lanes, C.E. Wentworth, M.H. Satterfield, B.L. Ahebe, and L.W. Dicker A metaregression analysis of the dose-response effect of aspirin on stroke Arch Intern Med 159 1999 1248 1253
79. M. Karabiyikoglu, Y. Hua, R.F. Keep, S.R. Ennis, and G. Xi Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow J Cereb Blood Flow Metab 24 2 2004, Feb. 159 166
80. I.L. Katzan, A.J. Furlan, and L.E. Lloyd Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience JAMA 283 2000 1151 1158
81. I.L. Katzan, M.D. Hammer, E.D. Hixson, A.J. Furlan, A. Abou-Chebl, and D.M. Nadzam Utilization of intravenous tissue plasminogen activator for acute ischemic stroke Arch Neurol 61 2004 346 350
82. R. Kay, K.S. Wong, and Y.L. Yu Low-molecular-weight heparin for the treatment of acute ischemic stroke N Engl J Med 333 1995 1588 1593
83. W.J. Koroshetz Warfarin, aspirin, and intracranial vascular disease N Engl J Med 352 2005 1368 1370
84. P. Koudstaal Secondary prevention following stroke or TIA in patients with nonrheumatic atrial fibrillation: anticoagulant therapy versus control (Cochrane review) The cochrane library 1999 Update Software Oxford
85. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
86. K.Y. Lee, D.I. Kim, S.H. Kim, S.I. Lee, H.W. Chung, and Y.W. Shim Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke Am J Neuroradiol 25 9 2004 1470 1475
87. M. Leist, P. Ghezzi, G. Grasso, R. Bianchi, and P. Villa Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 5681 2004 239 242
88. J. Leonardi-Bee, P.M.W. Bath, S.J. Philips, and P.A.G. Sandercock Blood pressure and clinical outcomes in the International Stroke Trial Stroke 33 2002 1315
89. C.A. Lewandowski, M. Frankel, and T.A. Tomsick Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial Stroke 30 1999 2598 2605
90. P.J. Lindsberg, L. Soinne, T. Tatlisumak, R.O. Roine, M. Kallela, and O. Happola Long-term outcome after intravenous thrombolysis of basilar artery occlusion JAMA 292 15 2004 1862 1866
91. P.S. Manoonkitiwongsa, R.L. Schultz, D.B. McCreery, E.F. Whitter, and P.D. Lyden Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis J Cereb Blood Flow Metab 24 6 2004 693 702
92. J. Martin, H. Meltzer, and D. Elliot OPCS surveys of disability in Great Britain report 1 The prevalence of disability among adults. Office of population censuses and surveys 1988 London HMSO
93. L. Martinsson, H.G. Hardemark, and N.G. Wahlgren Amphetamines for improving stroke recovery: a systematic cochrane review Stroke 34 11 2003 2766
94. J.L. Mas, C. Arquizan, C. Lamy, M. Zuber, L. Cabanes, and G. Derumeaux Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both N Engl J Med 345 24 2001 1740 1746
95. MAST-E: The Multicenter Acute Stroke Trial-Europe Study Group Thrombolytic therapy with streptokinase in acute ischemic stroke N Engl J Med 335 1996 145 150
96. MAST-I: The Multicentre Acute Stroke Trial-Italy Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
97. L. McCullough, L. Wu, N. Haughey, X. Liang, T. Hand, and Q. Wang Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia J Neurosci 24 1 2004 257 268
98. J.P. Mohr, J.L. Thompson, and R.M. Lazar A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke N Engl J Med 345 2001 1444 1451
99. C.A. Molina, J. Montaner, and S. Abilleira Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study Stroke 32 2001 2821 2827
100. E. Mori, Y. Yoneda, and M. Tabuchi Intravenous recombinant tissue plasminogen activator in acute carotid artery stroke Neurology 42 1992 976 982
101. K.W. Muir, and K.R. Lees Excitatory amino acid antagonists for acute stroke Cochrane Database Syst Rev 3 2003 (CD001244)
102. H. Nakatomi, T. Kuriu, S. Okabe, S. Yamamoto, O. Hatano, and N. Kawahara Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors Cell 110 4 2002 429 441
103. M. Nakayama, K. Uchimura, R.L. Zhu, T. Nagayama, M.E. Rose, and R.A. Stetler Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia Proc Natl Acad Sci U S A 95 1998 10954 10959
104. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial Tissue plasminogen activator for acute ischemic stroke NEJM 1995 1581 1587
105. N. Nighoghossian, M. Hermier, and P. Adeleine Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study Stroke 33 2002 735 742
106. S. Nogawa, F. Zhang, M.E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J Neurosci 17 1997 2746 2755
107. North American Symptomatic Carotid Endarterectomy Trial Collaboration Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
108. J. Oliveira-Filho, S.C. Silva, C.C. Trabuco, B.B. Pedreira, E.U. Sousa, and A. Bacellar Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset Neurology 61 8 2003 1047 1051
109. J. Pariente, I. Loubinoux, C. Carel, J.F. Albucher, A. Leger, and C. Manelfe Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke Ann Neurol 50 2001 718 729
110. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
111. Prospective Studies Collaboration Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts Lancet 346 1995 1647 1653
112. P.M. Ridker for the Cholesterol and Recurrent Events (CARE) Investigators Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
113. P.A. Ringleb, P.D. Schellinger, C. Schranz, and W. Hacke Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke Stroke 33 2002 1437 1441
114. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 13 1994 1449 1457
115. A. Rodgers, S. MacMahon, G. Gamble, J. Slattery, P. Sandercock, and C. Warlow Blood pressure and risk of stroke in patients with cerebrovascular disease BMJ 313 1996 147
116. A. Rodgers, B. Neal, and S. MacMahon The effects of blood pressure lowering in cerebrovascular disease Neurol Rev Int 2 1 1997 12 15
117. B. Roitberg Transplantation for stroke Neurol Res 26 3 2004 256 264
118. M.H. Rosove, and P.M. Brewer Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients Ann Intern Med 11 1992 303 308
119. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, and P. Theroux Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 12 2005 1179 1189
120. R.L. Sacco, M.A. Foulkes, J.P. Mohr, P.A. Wolf, D.B. Hier, and T.R. Price Determinants of early recurrence of cerebral infarction. The Stroke Data Bank Stroke 20 8 1989, Aug. 983 989
121. P. Sandercock Antiplatelet therapy with aspirin in acute ischaemic stroke Thromb Haemost 78 1997 180 182
122. P. Sandercock, O. Mielke, M. Liu, and C. Counsell Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (Cochrane Review) The cochrane library, issue 1 2004 Wiley Chichester, UK
123. J.L. Saver Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Novel derivation method and application to thrombolytic therapy for acute stroke Arch Neurol 61 2004 1066 1070
124. J.L. Saver, C. Kidwell, and M. Eckstein Prehospital neuroprotective therapy for acute stroke: results of the field administration of stroke therapy magnesium (FAST-MAG) pilot trial Stroke 35 2004 106 108
125. P.D. Schellinger, J.B. Fiebach, and W. Hacke Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status Stroke 34 2003 575 583
126. P.S. Sever, B. Dahlof, N.R. Poulter, H. Wedel, G. Beevers, and M. Caulfield Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Lancet 361 2003 1149
127. P. Sharma, and P. Bentley Of rats and men: superwarfarin toxicity Lancet 365 9459 2005 552 553
128. D.G. Sherman, R.P. Atkinson, and T. Chippendale Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial JAMA 282 2000 2395 2403
129. SITS-MOST. (2005). Safe Implementation of Thrombolysis in Stroke Monitoring Study. Available at: http://www.acutestroke.org. Accessed February 2005.
130. S.I. Sokol, E.L. Portnay, J.P. Curtis, M.A. Nelson, P.R. Hebert, and J.F. Setaro Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke Neurology 63 2 2004, Jul. 27 208 213
131. J.K. Song, E.D. Cacayorin, and M.S. Campbell Intracranial balloon angioplasty of acute terminal internal carotid artery occlusions Am J Neuroradiol 23 2002 1308 1312
132. SPORTIF III Investigators Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 2003 1691 1698
133. M. Sudlow, R. Thomson, B. Thwaites, H. Rodgers, and R.A. Kenny Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167 1171
134. G.K. Sukhova, J.K. Williams, and P. Libby Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arterioscler Thromb Vasc Biol 22 2002 1452 1458
135. D.W. Taylor, H.J. Barnett, and R.B. Haynes Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Collaborators Lancet 353 1999 2179 2184
136. A.J. Taylor, S.M. Kent, and P.J. Flaherty ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol. A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 2002 2055 2060
137. The INDIANA (Individual Data Analysis of Antihypertensive intervention trials) Project Collaborators Effect of antihypertensives treatment in patients having already suffered from stroke: gathering the evidence Stroke 28 1997 2557 2562
138. E.J. Topol, J.D. Easton, and R.A. Harrington Randomized double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease Circulation 108 2003 16 23
139. E. Touze, J.-Y. Gauvrit, and T. Moulin Risk of recurrent stroke and recurrent dissection after cervical artery dissection Neurology 61 2003 1347 1351
140. F. Turnbull, and Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535
141. S. Uchiyama, M. Yamazaki, and S. Maruyama Shear-induced platelet aggregation in cerebral ischaemia Stroke 25 1994 1547 1551
142. M. Vlcek, M. Schillinger, W. Lang, W. Lalouschek, A. Bur, and M.M. Hirschl Association between course of blood pressure within the first 24 hours and functional recovery after acute ischemic stroke Ann Emerg Med 42 5 2003, Nov. 619 626
143. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 7 2004, Jul. 1732 1737 (Epub 2004 Jun 3. Related Articles, Links)
144. J.M. Wardlaw, G. del Zoppo, and T. Yamaguchi Thrombolysis for acute ischaemic stroke (Cochrane Review) Cochrane Database Syst Rev 2000 3
145. WASID (The Warfarin-Aspirin Symptomatic Intracranial Disease Study) Prognosis of patients with symptomatic vertebral or basilar artery stenosis Stroke 29 1998 1389 1392
146. J.I. Weitz Low molecular-weight heparins N Engl J Med 337 1997 688 698
147. J.I. Weitz, B. Leslie, and M. Hudoba Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors Circulation 97 1998 544 552
148. B. Williams, N.R. Poulter, M.J. Brown, M. Davis, G.T. McInnes, and J.F. Potter Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV J Hum Hypertens 18 2004 139 185
149. J.L. Wilterdink, and J.D. Easton Dipyridamole plus aspirin in cerebrovascular disease Arch Neurol 56 1999 1087 1092
150. K. Yamagata, S. Ichinose, and M. Tagami Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats Hypertens Res 27 4 2004 271 282
151. S.S. Yoon, J. Dambrosia, J. Chalela, M. Ezzeddine, S. Warach, and J. Haymore Rising statin use and effect on ischemic stroke outcome BMC Med 2 2004 4
152. E.L. Zeuthen, J.F. Lassen, and S.E. Husted Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation? Thromb Res 109 5-6 2003, Mar. 15 241 246
153. R. Zhang, Z. Zhang, C. Zhang, L. Zhang, A. Robin, and Y. Wang Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat J Neurosci 24 25 2004 5810 5815